{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T01:47:25Z","timestamp":1751593645016,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100013371","name":"Universit\u00e9 C\u00f4te d\u2019Azur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013371","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-23-IAHU-007"],"award-info":[{"award-number":["ANR-23-IAHU-007"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011033","name":"Thermo Fisher Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00428-024-03933-2","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T03:32:39Z","timestamp":1727839959000},"page":"761-775","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Standardization through education of molecular pathology: a spotlight on the European Masters in Molecular Pathology"],"prefix":"10.1007","volume":"485","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2014-1236","authenticated-orcid":false,"given":"Marius","family":"Ili\u00e9","sequence":"first","affiliation":[]},{"given":"Vivien","family":"Lake","sequence":"additional","affiliation":[]},{"given":"Enrique","family":"de Alava","sequence":"additional","affiliation":[]},{"given":"Serena","family":"Bonin","sequence":"additional","affiliation":[]},{"given":"Sandra","family":"Chlebowski","sequence":"additional","affiliation":[]},{"given":"Aur\u00e9lie","family":"Delort","sequence":"additional","affiliation":[]},{"given":"Elisabeth","family":"Dequeker","sequence":"additional","affiliation":[]},{"given":"Raed","family":"Al-Dieri","sequence":"additional","affiliation":[]},{"given":"Arjan","family":"Diepstra","sequence":"additional","affiliation":[]},{"given":"Olli","family":"Carp\u00e9n","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Eloy","sequence":"additional","affiliation":[]},{"given":"Ambrogio","family":"Fassina","sequence":"additional","affiliation":[]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[]},{"given":"Pedro L.","family":"Fernandez","sequence":"additional","affiliation":[]},{"given":"Gregor","family":"Gorkiewicz","sequence":"additional","affiliation":[]},{"given":"Simon","family":"Heeke","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[]},{"given":"Gerald","family":"Hoefler","sequence":"additional","affiliation":[]},{"given":"Pablo","family":"Huertas","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Hummel","sequence":"additional","affiliation":[]},{"given":"Karl","family":"Kashofer","sequence":"additional","affiliation":[]},{"given":"Jeroen","family":"van der Laak","sequence":"additional","affiliation":[]},{"given":"Rocio Martinez","family":"de Pablos","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Schmitt","sequence":"additional","affiliation":[]},{"given":"Ed","family":"Schuuring","sequence":"additional","affiliation":[]},{"given":"Giorgio","family":"Stanta","sequence":"additional","affiliation":[]},{"given":"Wim","family":"Timens","sequence":"additional","affiliation":[]},{"given":"Benedikt","family":"Westphalen","sequence":"additional","affiliation":[]},{"given":"Paul","family":"Hofman","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"key":"3933_CR1","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41591-022-01717-2","volume":"28","author":"J Mateo","year":"2022","unstructured":"Mateo J, Steuten L, Aftimos P, Andre F, Davies M, Garralda E et al (2022) Delivering precision oncology to patients with cancer. Nat Med 28:658\u2013665","journal-title":"Nat Med"},{"key":"3933_CR2","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.ccell.2022.08.011","volume":"40","author":"D Akhoundova","year":"2022","unstructured":"Akhoundova D, Rubin MA (2022) Clinical application of advanced multi-omics tumor profiling: shaping precision oncology of the future. Cancer Cell 40:920\u2013938","journal-title":"Cancer Cell"},{"key":"3933_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejca.2022.09.005","volume":"176","author":"N Normanno","year":"2022","unstructured":"Normanno N, Apostolidis K, Wolf A, Al Dieri R, Deans Z, Fairley J et al (2022) Access and quality of biomarker testing for precision oncology in Europe. Eur J Cancer 176:70\u201377","journal-title":"Eur J Cancer"},{"key":"3933_CR4","doi-asserted-by":"publisher","first-page":"100838","DOI":"10.1016\/j.lanepe.2024.100838","volume":"38","author":"VD de Jager","year":"2024","unstructured":"de Jager VD, Timens W, Bayle A, Botling J, Brcic L, B\u00fcttner R et al (2024) Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries. Lancet Reg Health - Europe 38:100838","journal-title":"Lancet Reg Health - Europe"},{"key":"3933_CR5","doi-asserted-by":"publisher","first-page":"101628","DOI":"10.1016\/j.esmoop.2023.101628","volume":"8","author":"P Hofman","year":"2023","unstructured":"Hofman P, Calabrese F, Kern I, Adam J, Alarcao A, Alborelli I et al (2023) Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe. ESMO Open 8:101628","journal-title":"ESMO Open"},{"key":"3933_CR6","doi-asserted-by":"publisher","first-page":"e2100427","DOI":"10.1200\/PO.21.00427","volume":"6","author":"DS Bruno","year":"2022","unstructured":"Bruno DS, Hess LM, Li X, Su EW, Patel M (2022) Disparities in biomarker testing and clinical trial enrollment among patients with lung, breast, or colorectal cancers in the United States. JCO Precis Oncol 6:e2100427","journal-title":"JCO Precis Oncol"},{"key":"3933_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1515\/dx-2022-0115","volume":"10","author":"D Horgan","year":"2023","unstructured":"Horgan D, Hamdi Y, Lal JA, Nyawira T, Meyer S, Kondji D et al (2023) Empowering quality data - the Gordian knot of bringing real innovation into healthcare system. Diagnosis (Berl) 10:140\u2013157","journal-title":"Diagnosis (Berl)"},{"key":"3933_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.semcancer.2021.08.002","volume":"84","author":"N Normanno","year":"2022","unstructured":"Normanno N, Apostolidis K, de Lorenzo F, Beer PA, Henderson R, Sullivan R et al (2022) Cancer biomarkers in the era of precision oncology: addressing the needs of patients and health systems. Semin Cancer Biol 84:293\u2013301","journal-title":"Semin Cancer Biol"},{"key":"3933_CR9","doi-asserted-by":"publisher","first-page":"e23914","DOI":"10.1016\/j.heliyon.2023.e23914","volume":"10","author":"D Horgan","year":"2024","unstructured":"Horgan D, Van den Bulcke M, Malapelle U, Troncone G, Normanno N, Capoluongo ED et al (2024) Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems. Heliyon 10:e23914","journal-title":"Heliyon"},{"key":"3933_CR10","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.annonc.2020.07.014","volume":"31","author":"F Mosele","year":"2020","unstructured":"Mosele F, Remon J, Mateo J, Westphalen CB, Barlesi F, Lolkema MP et al (2020) Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group. Ann Oncol 31:1491\u20131505","journal-title":"Ann Oncol"},{"key":"3933_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.annonc.2022.12.009","volume":"34","author":"LE Hendriks","year":"2023","unstructured":"Hendriks LE, Kerr KM, Menis J, Mok TS, Nestle U, Passaro A et al (2023) Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 34:339\u2013357","journal-title":"Ann Oncol"},{"key":"3933_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/healthcare11030431","volume":"11","author":"D Horgan","year":"2023","unstructured":"Horgan D, Hamdi Y, Lal JA, Nyawira T, Meyer S, Kondji D et al (2023) Framework for adoption of next-generation sequencing (NGS) globally in the oncology area. Healthcare (Basel) 11:431","journal-title":"Healthcare (Basel)"},{"key":"3933_CR13","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1177\/0192623321989644","volume":"49","author":"P Moulin","year":"2021","unstructured":"Moulin P, Grunberg K, Barale-Thomas E, der Laak JV (2021) IMI-Bigpicture: a central repository for digital pathology. Toxicol Pathol 49:711\u2013713","journal-title":"Toxicol Pathol"},{"key":"3933_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00428-020-02757-0","volume":"476","author":"X Matias-Guiu","year":"2020","unstructured":"Matias-Guiu X, Stanta G, Carneiro F, Ryska A, Hoefler G, Moch H (2020) The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology. Virchows Arch 476:491\u2013497","journal-title":"Virchows Arch"},{"key":"3933_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/joim.13698","volume":"294","author":"A Stenzinger","year":"2023","unstructured":"Stenzinger A, Moltzen EK, Winkler E, Molnar-Gabor F, Malek N, Costescu A et al (2023) Implementation of precision medicine in healthcare-a European perspective. J Intern Med 294:437\u2013454","journal-title":"J Intern Med"},{"key":"3933_CR16","doi-asserted-by":"publisher","first-page":"894","DOI":"10.5858\/arpa.2014-0253-CP","volume":"139","author":"J Laudadio","year":"2015","unstructured":"Laudadio J, McNeal JL, Boyd SD, Le LP, Lockwood C, McCloskey CB et al (2015) Design of a genomics curriculum: competencies for practicing pathologists. Arch Pathol Lab Med 139:894\u2013900","journal-title":"Arch Pathol Lab Med"},{"key":"3933_CR17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jmoldx.2021.12.013","volume":"24","author":"ME Arcila","year":"2022","unstructured":"Arcila ME, Snow AN, Akkari YMN, Chabot-Richards D, Pancholi P, Tafe LJ (2022) Molecular pathology education: a suggested framework for primary care resident training in genomic medicine: a report of the Association for Molecular Pathology Training and Education Committee. J Mol Diagn 24:430\u2013441","journal-title":"J Mol Diagn"},{"key":"3933_CR18","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/jclinpath-2014-202404","volume":"67","author":"IA Cree","year":"2014","unstructured":"Cree IA, Deans Z, Ligtenberg MJ, Normanno N, Edsjo A, Rouleau E et al (2014) Guidance for laboratories performing molecular pathology for cancer patients. J Clin Pathol 67:923\u2013931","journal-title":"J Clin Pathol"},{"key":"3933_CR19","doi-asserted-by":"publisher","unstructured":"Platonova RI, Orekhovskaya NA, Dautova SB, Martynenko EV, Kryukova NI, Demir S (2022) Blended learning in higher education: diversifying models and practical recommendations for researchers. Frontiers in Education. [Review] 7.\u00a0https:\/\/doi.org\/10.3389\/feduc.2022.957199","DOI":"10.3389\/feduc.2022.957199"},{"key":"3933_CR20","first-page":"1","volume":"42","author":"D Rangachari","year":"2022","unstructured":"Rangachari D, Im A, Brondfield S (2022) Moving from theory to practice in oncology education when virtual is your reality. Am Soc Clin Oncol Educ Book 42:1\u201310","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"3933_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/educsci10040115","volume":"10","author":"HY Jang","year":"2020","unstructured":"Jang HY, Kim HJ (2020) A meta-analysis of the cognitive, affective, and interpersonal outcomes of flipped classrooms in higher education. Educ Sci 10:115","journal-title":"Educ Sci"},{"key":"3933_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/jpm12010072","volume":"12","author":"D Horgan","year":"2022","unstructured":"Horgan D, Curigliano G, Riess O, Hofman P, Buttner R, Conte P et al (2022) Identifying the steps required to effectively implement next-generation sequencing in oncology at a national level in Europe. J Pers Med 12:72","journal-title":"J Pers Med"},{"key":"3933_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/healthcare12020259","volume":"12","author":"D Horgan","year":"2024","unstructured":"Horgan D, Bulcke MVD, Malapelle U, Normanno N, Capoluongo ED, Prelaj A et al (2024) Aligning cancer research priorities in Europe with recommendations for conquering cancer: a comprehensive analysis. Healthcare (Basel) 12:259","journal-title":"Healthcare (Basel)"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03933-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-024-03933-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03933-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:05:10Z","timestamp":1731629110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-024-03933-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,2]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["3933"],"URL":"https:\/\/doi.org\/10.1007\/s00428-024-03933-2","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"type":"print","value":"0945-6317"},{"type":"electronic","value":"1432-2307"}],"subject":[],"published":{"date-parts":[[2024,10,2]]},"assertion":[{"value":"29 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M. Ili\u00e9: honoraria from AstraZeneca and MSD, and research funding from Amgen. A. Diepstra: research funding from Takeda. C. Eloy: advisory role for MSD, Leica, Diapath, Biocartis, Sakura, Mindpeak. F. Fend: research funding from Stemline; speaker honoraria from Stemline, EUSA Pharma. G. Hoefler: honoraria from AstraZeneca, Elsevier, MSD, Novartis, BioProducts. M. Hummel: honoraria for Novartis, AstraZeneca. E. Schuuring reports lectures for Bio-Rad, Seracare, Roche, Biocartis, Illumina, Lilly, Janssen Cilag (Johnson&Johnson), AstraZeneca, and Agena Bioscience; he is consultant in advisory boards for MSD\/Merck, GSK, AstraZeneca, Astellas Pharma, Sysmex, Roche, Novartis, Bayer, BMS, Lilly, Amgen, Illumina, Agena Bioscience, Janssen Cilag (Johnson&Johnson), Sinnovisionlab, Diaceutics, CC Diagnostics; and received research grants from Biocartis, Invitae-ArcherDX, AstraZeneca, Agena Bio-science, BMS, Bio-Rad, Roche, Boehringer Ingelheim, CC Diagnostics, SNN\/EFRO, and Abbott (all paid to UMCG account); and travel reimbursements from Bio-Rad, Abbott, Illumina, Agena Bioscience, Roche, IQNPath, and BioRAD. W. Timens: honororia to UMCG from Bristol-Myers Squibb, Merck Sharp Dohme. C. Benedikt Westphalen: has received honoraria from Amgen, Bayer, BMS, Chugai, Celgene, Falk, GSK, Janssen, Ipsen, MSD, Merck, Roche, Servier, SIRTeX, Taiho; served on advisory boards for Bayer, BMS, Celgene, Incyte, Janssen, Lily, MSD, Servier, Shire\/Baxalta, Rafael Pharmaceuticals, RedHill, Roche, has received travel support by Bayer, Celgene, Janssen, RedHill, Roche, Servier, Taiho and research grants (institutional) from Roche; serves as faculty for European Society of Medical Oncology (ESMO), Deutsche Krebshilfe (DKH), and Arbeitsgemeinschaft internistische Onkologie (AIO), is a member of the EU Commission expert group: mission board for cancer; is a member of the forum #Zukunftsstrategie of the German government. P. Hofman: advisory role for: Sanofi, Amgen, Roche, Abbvie, BMS, AstraZeneca, Pfizer, Janssen, Pierre Fabre, ThermoFisher Scientific, Qiagen, Diaceutics, Novartis, Biodena, Biocartis, Eli Lilly; honoraria from: Sanofi, Amgen, Roche, BMS, AstraZeneca, Abbvie, Qiagen, Pfizer, Janssen, Pierre Fabre, ThermoFisher Scientific, Biodena, Diaceutics, Biocartis, Daiichi-Sankyo, Eli Lilly, Bayer, Novartis, Bayer; grant\/research funding from: Amgen, Thermo-Fisher Scientific, Biodena, Roche. The remaining authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}